These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current trends in diagnosis and management of cardiac amyloidosis. Esplin BL; Gertz MA Curr Probl Cardiol; 2013 Feb; 38(2):53-96. PubMed ID: 23337445 [TBL] [Abstract][Full Text] [Related]
4. Amyloid heart disease: a brief review of treatment options. Dubrey SW Postgrad Med J; 2012 Dec; 88(1046):700-5. PubMed ID: 22745180 [TBL] [Abstract][Full Text] [Related]
5. Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. Gregorini G; Izzi C; Obici L; Tardanico R; Röcken C; Viola BF; Capistrano M; Donadei S; Biasi L; Scalvini T; Merlini G; Scolari F J Am Soc Nephrol; 2005 Dec; 16(12):3680-6. PubMed ID: 16221867 [TBL] [Abstract][Full Text] [Related]
6. [Familial approach in hereditary transthyretin cardiac amyloidosis]. García-Pavía P; Avellana P; Bornstein B; Heine-Suñer D; Cobo-Marcos M; Gómez-Bueno M; Segovia J; Alonso-Pulpón LA Rev Esp Cardiol; 2011 Jun; 64(6):523-6. PubMed ID: 21439703 [TBL] [Abstract][Full Text] [Related]
7. Nephrotic syndrome due to an amyloidogenic mutation in fibrinogen A alpha chain. Picken MM; Linke RP J Am Soc Nephrol; 2009 Aug; 20(8):1681-5. PubMed ID: 19092118 [TBL] [Abstract][Full Text] [Related]
8. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Picken MM Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662 [TBL] [Abstract][Full Text] [Related]
14. Novel clinical manifestations and treatment of hereditary apoA-I amyloidosis: when a good protein turns bad. Gursky O Kidney Int; 2020 Jul; 98(1):62-64. PubMed ID: 32571494 [TBL] [Abstract][Full Text] [Related]
15. [Systemic amyloidoses--new treatment methods make early and exact diagnosis more and more important]. Westermark P Lakartidningen; 2007 May 9-15; 104(19):1517-21. PubMed ID: 17550030 [No Abstract] [Full Text] [Related]
17. Hereditary fibrinogen A alpha-chain amyloidosis. Lane SW; Goodman HJ; Francis L; Bofinger A; Mollee PN Pathology; 2006 Aug; 38(4):380-2. PubMed ID: 16916739 [No Abstract] [Full Text] [Related]
18. Periorbital ecchymoses are not pathognomonic of the light-chain type of amyloidosis. Outteryck O; Stojkovic T; Launay D; Meignie-Ramon B; Vermersch P Acta Derm Venereol; 2007; 87(6):544-5. PubMed ID: 17989898 [No Abstract] [Full Text] [Related]
19. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis. Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661 [TBL] [Abstract][Full Text] [Related]
20. [Systemic AA amyloidosis induced by benign neoplasms]. Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]